Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-016097

EVP, Growth Markets Commercial sold 512 shares at $16.88 ($8,645)

  • EVP, Growth Markets Commercial acquired 1,399 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nazzi Gianfranco · EVP, Growth Markets Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-03 Exercise or conversion : show line 1 in the form +1,399 8,404.36 D
2019-03-04 Sale : show line 2 in the form −512 $16.88 $8,645 7,892.36 D
Open-market sales · 512 sh · avg $16.88 · $8,645

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-03 Exercise or conversion : show line 3 in the form Restricted Share Units −1,399 2,799 D
Loading xslF345X03/doc4.xml…